CI & Patent News: 20/11/2010


1) GlaxoSmithKline and Fiocruz extend innovative collaboration to research and develop new medicines for neglected tropical diseases (Press Release)

… This new collaborative framework, builds on a long-standing relationship between Fiocruz and GlaxoSmithKline, established in 1985, to manufacture vaccines for public health priorities in Brazil.  These include polio, Haemophilus influenzae type b (Hib), measles, mumps, rubella, rotavirus and most recently pneumococcal disease. The relationship has also supported the development of research and manufacturing capabilities in Brazil through technology transfer and scientific collaboration… Priority areas include Malaria, Tuberculosis, Chagas and Leishmaniasis.

2) India’s Sun Pharma Clears FDA On Generic Clarinex® — But No Sales Until Mid-2012 (New Merck, Reviewed)

3) Cephalon Loses U.K. Bid to Halt Mylan, Orchid Generic-Drug Sales (Bloomberg) (Order)

4) Apixaban: Pfizer halts blood thinner study due to bleeding (Yahoo Finance) (BMS)

5) Axitinib: Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC) (Press release)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s